Suppr超能文献

肠道微生物群产生的小檗碱生物活性代谢物可改善能量代谢。

Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.

机构信息

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences / Peking Union Medical College, Beijing, 100050, China.

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences / Peking Union Medical College, Beijing, 100050, China.

出版信息

Metabolism. 2017 May;70:72-84. doi: 10.1016/j.metabol.2017.02.003. Epub 2017 Feb 10.

Abstract

OBJECTIVE

Berberine (BBR) clinically lowers blood lipid and glucose levels via multi-target mechanisms. One of the possible mechanisms is related to its effect on the short chain fatty acids (SCFAs) of the gut microbiota. The goal of this study is to investigate the therapeutic effect and mode of action of BBR working through SCFAs of the gut microbiota (especially, butyrate).

METHODS

Gas chromatography (GC) was used to detect butyrate and other SCFAs chemically. The effect of BBR on butyrate production was investigated in vitro as well as in several animal systems. Microarrays were used to analyze the composition change in the intestinal bacteria community after treatment with BBR. BBR-induced change in the energy production and gene regulation of intestinal bacteria was examined in order to elucidate the underlying molecular mechanisms.

RESULTS

We show that oral administration of BBR in animals promoted the gut microbiota to produce butyrate, which then enters the blood and reduces blood lipid and glucose levels. Incubating gut bacterial strains in vitro with BBR increased butyrate production. Orally treating animals directly with butyrate reduced blood lipid and glucose levels through a mechanism different from that of BBR. Intraperitoneal BBR administration did not increase butyrate but reduced blood lipid and glucose levels, suggesting that BBR has two modes of action: the direct effect of the circulated BBR and the indirect effect working through butyrate of the gut microbiota. Pre-treating animals orally with antibiotics abolished the effect of BBR on butyrate. A mechanism study showed that BBR (given orally) modified mice intestinal bacterial composition by increasing the abundance of butyrate-producing bacteria. Furthermore, BBR suppressed bacterial ATP production and NADH levels, resulting in increased butyryl-CoA and, eventually, butyrate production via upregulating phosphotransbutyrylase/butyrate kinase and butyryl-CoA:acetate-CoA transferase in bacteria.

CONCLUSION

Promotion of butyrate (etc) production in gut microbiota might be one of the important mechanisms of BBR in regulating energy metabolism.

摘要

目的

小檗碱(BBR)通过多靶点机制降低血脂和血糖水平。其可能的作用机制之一与肠道微生物群的短链脂肪酸(SCFAs)有关。本研究旨在探讨 BBR 通过肠道微生物群的 SCFAs(特别是丁酸盐)发挥治疗作用和作用模式。

方法

采用气相色谱(GC)法检测丁酸盐等 SCFAs 的化学变化。体外和几种动物系统研究 BBR 对丁酸盐产生的影响。用微阵列分析 BBR 处理后肠道细菌群落的组成变化。为阐明潜在的分子机制,检测了 BBR 诱导的肠道细菌能量产生和基因调节变化。

结果

我们表明,动物口服 BBR 可促进肠道微生物群产生丁酸盐,然后丁酸盐进入血液并降低血脂和血糖水平。体外培养肠道细菌株与 BBR 孵育可增加丁酸盐的产生。直接口服动物丁酸盐可通过不同于 BBR 的机制降低血脂和血糖水平。腹腔内 BBR 给药不会增加丁酸盐,但会降低血脂和血糖水平,这表明 BBR 有两种作用模式:循环 BBR 的直接作用和肠道微生物群丁酸盐的间接作用。动物口服抗生素预处理可消除 BBR 对丁酸盐的作用。机制研究表明,BBR(口服)通过增加产丁酸盐细菌的丰度来改变小鼠肠道细菌组成。此外,BBR 抑制细菌 ATP 产生和 NADH 水平,通过上调细菌中的磷酸转丁酰酶/丁酸盐激酶和丁酰 CoA:乙酰 CoA 转移酶,最终增加丁酰 CoA,从而产生丁酸盐。

结论

促进肠道微生物群中丁酸盐(等)的产生可能是 BBR 调节能量代谢的重要机制之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验